Cervical cancer detection platform based on novel laser processing
Within the scope of this project a highly sensitive platform to detect Human Pappliomavirus (HPV), causative agent of about 99.7% of cervical cancer will be developed. The proposed diagnostic platform will be based on laser textured biopolymer as a device substrate, functionalized with nanoparticles produced via Pulsed Laser Ablation in Liquid (PLAL) technique. This on-chip immunoassay will allow rapid detection of the HPV. The novelty of this project lies in the high-quality bio-nanostructures as nano-labels via PLAL designed for ultrasensitive detection of HPV. Two major aspects of this project are: (1) the development of complex nano-labels specifically targeting high risk HPV; (2) improvement in the performance of the developed assay system by increasing their sensitivity and specificity.
Arrows Biomedical GmbH, NASA Aimes Lab, Standford University
Marie Curie Action
- Congratulations to APT PI, Prof Fiona Regan, recently awarded the @RoySocChem Water Science Forum “Water for Life Award” 2019.
- DCU&DkIT Business Matchmaker and Research Showcase 2019
- I-Form Metal Additive Manufacturing Lab Inauguration Ceremony April 5th 2019
- Congratulations to APT PI Prof Patrick McNally for his involvement in a new European project
- New Microbial Processing Facility Inauguration May 29th 2019